Oxford BioDynamics EpiSwitch Test Included In Cancer Screening Study
LONDON (Alliance News) - Oxford BioDynamics PLC on Tuesday said it has signed an agreement for its EpiSwitch test to be used by Imperial College London in a prostate cancer screening College is to Read More